4.8 Article

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery

Related references

Note: Only part of the references are listed.
Review Microbiology

Gut microbiota in human metabolic health and disease

Yong Fan et al.

Summary: The intestinal microbiota plays a significant role in human metabolic health, potentially contributing to the development of common metabolic disorders when dysregulated. Current research is shifting towards cause-and-effect studies and utilizing high-throughput human multi-omics data to identify potential molecular mechanisms behind these associations.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Gastroenterology & Hepatology

Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease

John P. Haran et al.

Summary: The human gut microbiome, consisting of bacteria, protozoa, fungi, and viruses, plays essential roles in protecting, metabolizing, and maintaining human health. Imbalances within the intestinal microbial community structure are increasingly recognized as being involved in disease processes across various organ systems, particularly due to untoward inflammatory responses. Recent advances in understanding the microbiome's role in aging have opened the door for potential novel therapeutics targeting a less dysbiotic microbiome to prevent or treat age-related diseases.

GASTROENTEROLOGY (2021)

Review Rheumatology

The gut-joint axis in rheumatoid arthritis

Mario M. Zaiss et al.

Summary: The review discusses the role of intestinal dysbiosis in rheumatoid arthritis and highlights the potential pathogenic role of gut-derived immune cells in the joints. It also explores the hypothesis that alterations in the microbial flora may precede the onset of RA and suggests that modulation of intestinal microbiota could be a potential therapeutic approach for preventing or treating RA.

NATURE REVIEWS RHEUMATOLOGY (2021)

Article Cell Biology

Smectite promotes probiotic biofilm formation in the gut for cancer immunotherapy

Congwei Han et al.

Summary: Administration of smectite promotes expansion of probiotics in the gut, which enhances anti-tumor immune responses in mice.

CELL REPORTS (2021)

Article Microbiology

Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models

Francesco Strati et al.

Summary: Different antibiotic treatments influence the gut microbiota's ability to control intestinal inflammation by altering the microbial community structure and production of metabolites, as observed in experimental colitis models.

MICROBIOME (2021)

Article Chemistry, Multidisciplinary

Optotheranostic Nanosystem with Phone Visual Diagnosis and Optogenetic Microbial Therapy for Ulcerative Colitis At-Home Care

Meihui Cui et al.

Summary: A study developed an optotheranostic nanosystem for self-diagnosis and long-acting mitigation of ulcerative colitis (UC). The system utilized smartphone optical sensing for disease prescreening and an optogenetic engineered bacteria system for real-time intervention. Treatment with IL-10-secreting EcN effectively suppressed intestinal inflammatory response and protected intestinal mucosa in UC mice.

ACS NANO (2021)

Article Multidisciplinary Sciences

Mucosal immunity-mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer's patches

Sisi Lin et al.

Summary: The oral delivery of camouflaged probiotics can induce mucosal immune responses, regulate the gut microbiota, maintain gut homeostasis, and provide defense against external threats. Studies show that this approach effectively prevents intestinal barrier breakdown, bacterial translocation, and systemic inflammation.

SCIENCE ADVANCES (2021)

Article Microbiology

Alterations in the gut microbiota contribute to cognitive impairment induced by the ketogenic diet and hypoxia

Christine A. Olson et al.

Summary: Many genetic and environmental factors increase susceptibility to cognitive impairment, and the gut microbiome is implicated in this process. Carbohydrate-restricted diet exacerbates cognitive impairment induced by intermittent hypoxia in mice and alters gut microbiota composition. Specific gut bacteria have been identified to contribute to inflammation and hippocampal dysfunction, thus increasing the risk of cognitive impairment in mice.

CELL HOST & MICROBE (2021)

Article Cell Biology

The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease

Han Zhu et al.

Summary: The study demonstrates that oral administration of the probiotic Lactobacillus casei Zhang can correct gut microbial dysbiosis, alleviate kidney injury, and delay the progression of chronic kidney disease. By increasing levels of SCFAs and nicotinamide, L. casei Zhang shows potential as a therapy to reduce renal inflammation and slow the decline of kidney function.

CELL METABOLISM (2021)

Article Engineering, Biomedical

Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel

Kai Han et al.

Summary: Modulating the gut microbiome with orally administered gel can induce systemic antitumour immunity and enhance the activity of immune checkpoint inhibitors in murine tumour models. This method shows promise for treating pathologies associated with dysregulated gut microbiome.

NATURE BIOMEDICAL ENGINEERING (2021)

Review Gastroenterology & Hepatology

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

Aonghus Lavelle et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Agriculture, Multidisciplinary

Modulation of Gut Microbiota by Fucoxanthin During Alleviation of Obesity in High-Fat Diet-Fed Mice

Xiaowen Sun et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)

Article Multidisciplinary Sciences

Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity

Daniel S. Leventhal et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Developing a new class of engineered live bacterial therapeutics to treat human diseases

Mark R. Charbonneau et al.

NATURE COMMUNICATIONS (2020)

Editorial Material Microbiology

Moving from probiotics to precision probiotics

Patrick Veiga et al.

NATURE MICROBIOLOGY (2020)

Review Pharmacology & Pharmacy

Polymeric carriers for enhanced delivery of probiotics

Shadi Asgari et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

Article Chemistry, Multidisciplinary

On-Demand Bacterial Reactivation by Restraining within a Triggerable Nanocoating

Pingping Feng et al.

ADVANCED MATERIALS (2020)

Article Multidisciplinary Sciences

Bioinspired oral delivery of gut microbiota by self-coating with biofilms

Xinyue Wang et al.

SCIENCE ADVANCES (2020)

Article Multidisciplinary Sciences

Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy

Yufeng Liu et al.

SCIENCE ADVANCES (2020)

Article Chemistry, Multidisciplinary

An Orally Administered CeO2@Montmorillonite Nanozyme Targets Inflammation for Inflammatory Bowel Disease Therapy

Shengwc. Zhao et al.

ADVANCED FUNCTIONAL MATERIALS (2020)

Article Biotechnology & Applied Microbiology

Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosis

Poshen B. Chen et al.

NATURE BIOTECHNOLOGY (2020)

Article Multidisciplinary Sciences

Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy

Lukas F. Mager et al.

SCIENCE (2020)

Article Microbiology

Adaptive Strategies of the Candidate Probiotic E. coli Nissle in the Mammalian Gut

Nathan Crook et al.

CELL HOST & MICROBE (2019)

Review Biotechnology & Applied Microbiology

Synthetic Biology Tools to Engineer Microbial Communities for Biotechnology

Nicholas S. McCarty et al.

TRENDS IN BIOTECHNOLOGY (2019)

Article Biochemistry & Molecular Biology

Programmable bacteria induce durable tumor regression and systemic antitumor immunity

Sreyan Chowdhury et al.

NATURE MEDICINE (2019)

Article Chemistry, Multidisciplinary

A Probiotic Spore-Based Oral Autonomous Nanoparticles Generator for Cancer Therapy

Qingling Song et al.

ADVANCED MATERIALS (2019)

Article Multidisciplinary Sciences

Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut

Pichet Praveschotinunt et al.

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts

Raymond W. Bourdeau et al.

NATURE (2018)

Article Biotechnology & Applied Microbiology

Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria

Vincent M. Isabella et al.

NATURE BIOTECHNOLOGY (2018)

Review Oncology

Tumour-targeting bacteria engineered to fight cancer

Shibin Zhou et al.

NATURE REVIEWS CANCER (2018)

Article Biochemical Research Methods

Chemically induced mouse models of acute and chronic intestinal inflammation

Stefan Wirtz et al.

NATURE PROTOCOLS (2017)

Article Chemistry, Multidisciplinary

Layer-by-Layer Encapsulation of Probiotics for Delivery to the Microbiome

Aaron C. Anselmo et al.

ADVANCED MATERIALS (2016)

Article Multidisciplinary Sciences

Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons

Sonia A. Ballal et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Cell Biology

An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease

Sufeng Zhang et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Review Pediatrics

Inflammatory Bowel Disease in Children and Adolescents

Michael J. Rosen et al.

JAMA PEDIATRICS (2015)

Article Gastroenterology & Hepatology

Adverse effects of biologics used for treating IBD

Andreas Stallmach et al.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)

Review Immunology

Intestinal mucosal barrier function in health and disease

Jerrold R. Turner

NATURE REVIEWS IMMUNOLOGY (2009)